Fund Team

teamwork

Extensive Investment and Portfolio Track Record

Team track record collectively reflects significant AUM, multiple fund exits, and realized venture exits (including IPOs) strongly aligned with the investment thesis and target returns for Maroon Catalytic Growth Capital.

Fund investment team members are not first-time GPs, and have a proven investment track record as institutional LPs, fund managers, and successful venture builders who have scaled and exited early stage & growth equity ventures and funds in the Fund’s target Health and Climate sectors; while astutely managing portfolio risk and delivering attractive risk-adjusted returns.

Maroon Catalytic Growth Capital reflects the extensive credit/ portfolio risk management expertise of the team, deep diligence investment process, and differentiated portfolio construction providing greater risk mitigation and downside protection for LPs.

The Fund is a true leader in GP accountability with clear and material Fund Financial KPIs governing GP carry.
‍
Lisa Lambie

Lisa Lambie

MANAGING PARTNER
  • 20+ yr track record as successful Institution Builder, Investor, and transformative leader across Credit Risk, Venture & Growth Equity
  • $1.4bn+ invested and structured incl. Growth Equity Fund as GP & LP
  • Catalytic Investor-Operator with extensive expertise delivering strong performance across sectors, volatile economic cycles & markets
  • JP Morgan, BAML Securities, Cordiant, Barclays, NCB, Wharton Impact Investment Partners
  • Board Member, Maroon Research Institute Global and Platform Founder of award-winning ventures
  • Successful Family business in Precision Medicine, Genomics & Preventative Health
  • Family Office Leadership as Seed Investor in SHIL Advisory, 250+ FON
  • MBA, Finance, The Wharton School; BSE, Civil Engineering, Princeton University
Vatsala Arunachalam

Vatsala Arunachalam

General Partner
  • 15+ yrs in Venture Capital, AlternativeInvestments, M&A, structured credit, special situations
  • $500mm AUM invested incl. 10 Funds, direct, and strategic investments
  • 4.0x MOIC and 4 Fund exits
  • Sector expertise in Healthcare and Infrastructure
  • Family Office and LP-GP portfolio management
Timmeko MOORE Love

Timmeko MOORE Love

General Partner
  • 17-yr track record as Institutional GP and LP in Venture Capital
  • $600mm AUM in fund and venture investments
  • 6.8x MOIC, 16 Venture Exits, LP in 3 Funds
  • Investment Committee & Investor, Mayo Clinic Ventures
  • Managing Partner, Mayo Clinic Accelerator
  • MD, Entergy Ventures; Best Buy Capital
  • SVP, Greentown Labs
  • MBA – Columbia Business School
  • MSc, Engineering Physics – Cornell University
  • BSc, Applied Physics - Florida A&M
Mattan Lurie

Mattan Lurie

Venture Partner
  • Venture Partner & Director, Maroon Global Ventures (Hong Kong) Ltd
  • 15+ yrs in Private Equity, Venture Capital
  • Prior positions at Credit Lyonnais, Fosun(China’s largest private company)
  • Strategic cross-border investments, M&A
  • Hony Capital (China’s leading PE Fund),with $9 bn AUM incl. LPs ~ Bill Gates, Stanford, Goldman Sachs, Temasek,Rothschild
  • Fluent in Mandarin Chinese and Hebrew
Mark Crawford

Mark Crawford

Investment Committee Member & LP CO-INVESTOR
  • 20-yr track record in Venture Capital as a LP in fund and venture investments
  • $5.4bn AUM to date; 6 Venture Exits, LP in 12 VC Funds
  • MD, Caterpillar Ventures
  • MD, Stanley Ventures
  • Director, Intel Capital VC
  • CEO, Invest Nebraska Corporation
  • MD, Performant Capital Partners LP
  • MBA – American University
  • BA – Tufts University
Anil Poonampalam

Anil Poonampalam

Investment Committee Member
  • Fund Manager for Variable Capital Companies (Singapore, Hong Kong) of Maroon Catalytic Growth Capital and sub-funds
  • IQ-EQ Head of Business & Investments (Asia & GCC) with $23bn AUM across venture capital, private equity, mezzanine/ debt, infrastructure and liquid investments
  • 20+ yr track record including at Daiwa Sumitomo Bank, Development Bank of Singapore (DBS), Orion Capital
  • Monetary Authority of Singapore, Singapore Institute of Directors & Director with Cayman Islands Monetary Authority
(Dato) Anusha Santhirasthipam

(Dato) Anusha Santhirasthipam

Strategic Advisor
  • Shareholder of Blue Oasis Partners (affiliate of Maroon Catalytic Growth Capital) focused on health-enabling infrastructure, property, and the built environment
  • 30+ yrs award-winning track record specializing in Asia investments, M&A, strategic regional expansion, innovation and tech transfer for nation-wide socioeconomic transformation
  • $5.0bn AUM to institutional investors (sovereign wealth funds, pension funds)
  • 300+ public listings
  • Exclusive Advisor & Mandates from leading LPs, family conglomerates and government entities